marketcaparena
Search

    ZVRA

    ZEVRA THERAPEUTICS, INC.

    Company overview

    Market capitalization
    $671.04M
    Employees
    61
    Latest publication
    2026-09-29
    About ZEVRA THERAPEUTICS, INC.

    Zevra Therapeutics, Inc., a commercial-stage company, focuses on addressing unmet needs for the treatment of rare diseases in the United States. The company develops its products through Ligand Activated Technology platform. Its lead product candidate is KP1077, consisting of KP1077IH, which is under Phase 3 clinical trial for the treatment of idiopathic hypersomnia, and KP1077N, which is under Phase 3 clinical trial to treat narcolepsy. The company is developing Celiprolol, an investigational product candidate that is under Phase 3 clinical trial for the treatment of vascular Ehlers Danlos syndrome. In addition, it offers AZSTARYS, a once-daily treatment for attention deficit and hyperactivity disorder in patients aged six years and older; OLPRUVA to treat urea cycle disorders; and MIPLYFFA for the treatment of niemann-pick disease type C, an ultra-rare neurodegenerative disease. The company has collaboration and license agreement with Commave Therapeutics SA to develop, manufacture and commercialize the company's product candidates containing SDX and d-methylphenidate; and license agreement with Acer and Relief Therapeutics, Inc. to develop and commercialize rights for OLPRUVA. The company was formerly known as KemPharm, Inc. and changed its name to Zevra Therapeutics, Inc. in February 2023. The company was incorporated in 2006 and is headquartered in Boston, Massachusetts.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue39,663,000USD36,220,000USD106,500,000USD26,063,000USD25,881,000USD20,401,000USD12,043,000USD3,695,000USD
    Cost Of Revenue1,525,000USD1,897,000USD—1,238,000USD12,379,000USD1,345,000USD1,366,000USD2,303,000USD
    Gross Profit38,138,000USD34,323,000USD—24,825,000USD13,502,000USD19,056,000USD10,677,000USD1,392,000USD
    Selling General Administrative16,559,000USD20,783,000USD—16,935,000USD20,782,000USD19,545,000USD1,604,000USD16,208,000USD
    Other Operating Expenses316,000USD———————
    Total Operating Expenses21,361,000USD-17,823,000USD—20,682,000USD84,541,000USD24,418,000USD26,093,000USD28,698,000USD
    Operating Income16,777,000USD52,146,000USD—4,143,000USD-71,039,000USD-5,362,000USD-15,416,000USD-27,306,000USD
    Total Other Income Expense Net-3,983,000USD-7,342,000USD—-5,120,000USD147,945,000USD3,445,000USD-4,952,000USD-5,919,000USD
    Interest Expense0USD1,711,000USD—2,051,000USD2,009,000USD1,969,000USD2,194,000USD2,312,000USD
    Income Before Tax12,794,000USD44,804,000USD—-977,000USD76,906,000USD-1,917,000USD-20,368,000USD-33,225,000USD
    Income Tax Expense4,042,000USD6,914,000USD—-433,000USD2,199,000USD1,182,000USD15,371,000USD—
    Net Income8,752,000USD37,890,000USD83,200,000USD-544,000USD74,707,000USD-3,099,000USD-35,739,000USD-33,225,000USD
    Research Development—4,392,000USD—3,432,000USD3,433,000USD3,258,000USD9,914,000USD10,945,000USD
    Net Income Applicable To Common Shares—36,317,000USD—-544,000USD67,909,000USD———
    Unclassified Operating Expenses—————1,615,000USD—1,545,000USD
    Interest Income—————543,000USD73,000USD1,049,000USD
    Net Interest Income—————-1,426,000USD-2,267,000USD-1,263,000USD
    Tax Provision—————1,182,000USD15,371,000USD0USD
    Net Income From Continuing Ops—————-3,099,000USD-35,739,000USD-33,225,000USD
    Ebit—————52,000USD-18,174,000USD-30,913,000USD
    Ebitda—————1,701,000USD-16,526,000USD-29,296,000USD
    Depreciation And Amortization—————1,649,000USD1,648,000USD1,617,000USD
    Reconciled Depreciation—————1,649,000USD1,648,000USD1,617,000USD
    Selling And Marketing Expenses——————14,521,000USD—
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosurePreliminaryDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Revenue106,470,000USD23,612,000USD27,461,000USD10,161,000USD28,650,000USD13,288,000USD12,839,000USD—
    Cost Of Revenue16,482,000USD7,417,000USD2,945,000USD222,000USD2,059,000USD1,305,000USD2,945,000USD324,000USD
    Gross Profit89,988,000USD16,195,000USD24,516,000USD9,939,000USD26,591,000USD11,983,000USD9,894,000USD-324,000USD
    Research Development12,743,000USD42,095,000USD39,806,000USD19,803,000USD10,161,000USD8,843,000USD19,415,000USD41,759,000USD
    Selling General Administrative77,616,000USD54,868,000USD24,734,000USD15,343,000USD8,701,000USD7,921,000USD10,816,000USD12,508,000USD
    Total Operating Expenses152,931,000USD103,198,000USD74,120,000USD52,504,000USD18,862,000USD17,592,000USD30,231,000USD54,267,000USD
    Operating Income-62,943,000USD-87,003,000USD-49,604,000USD-42,565,000USD7,729,000USD-5,609,000USD-20,337,000USD-55,903,000USD
    Total Other Income Expense Net149,621,000USD-3,137,000USD3,555,000USD15,760,000USD-16,250,000USD-7,185,000USD-4,207,000USD-689,000USD
    Interest Expense7,977,000USD7,351,000USD1,501,000USD335,000USD376,000USD7,090,000USD6,514,000USD7,087,000USD
    Income Before Tax86,678,000USD-90,140,000USD-46,049,000USD-26,805,000USD-8,521,000USD-12,794,000USD-24,544,000USD-56,592,000USD
    Income Tax Expense3,449,000USD15,371,000USD—-33,000USD34,000USD-34,000USD-22,000USD-126,000USD
    Net Income83,229,000USD-105,511,000USD-46,049,000USD-26,772,000USD-8,555,000USD-12,760,000USD-24,522,000USD-56,466,000USD
    Net Income Applicable To Common Shares77,585,000USD——-41,543,000USD-62,897,000USD-12,760,000USD-24,522,000USD—
    Unclassified Operating Expenses—6,235,000USD9,580,000USD17,053,000USD————
    Interest Income—2,175,000USD4,609,000USD760,000USD248,000USD89,000USD309,000USD—
    Net Interest Income—-5,176,000USD3,694,000USD425,000USD-128,000USD-7,001,000USD-6,205,000USD—
    Tax Provision—15,371,000USD-34,000USD-786,000USD34,000USD-34,000USD-22,000USD—
    Net Income From Continuing Ops—-105,511,000USD-39,917,000USD-41,543,000USD-8,555,000USD-12,760,000USD-24,522,000USD—
    Ebit—-82,789,000USD-44,548,000USD-26,470,000USD-8,145,000USD-5,704,000USD-18,030,000USD-54,267,000USD
    Ebitda—-76,400,000USD-43,542,000USD-25,526,000USD-7,888,000USD-5,431,000USD-17,726,000USD-53,943,000USD
    Depreciation And Amortization—6,389,000USD1,006,000USD944,000USD257,000USD273,000USD304,000USD324,000USD
    Reconciled Depreciation—6,389,000USD519,000USD944,000USD257,000USD273,000USD304,000USD—
    Selling And Marketing Expenses———305,000USD————
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets302,712,000USD278,579,000USD284,731,000USD270,116,000USD256,277,000USD172,708,000USD178,127,000USD191,551,000USD
    Cash And Equivalents145,321,000USD95,595,000USD62,406,000USD54,439,000USD47,712,000USD———
    Total Current Assets251,302,000USD229,968,000USD223,007,000USD225,115,000USD226,337,000USD81,573,000USD86,027,000USD99,442,000USD
    Other Current Assets4,794,000USD4,944,000USD6,998,000USD7,398,000USD4,352,000USD3,766,000USD4,052,000USD2,276,000USD
    Other Non Current Assets3,000USD143,000USD143,000USD153,000USD220,000USD———
    Total Liabilities85,060,000USD72,775,000USD130,074,000USD136,951,000USD139,047,000USD———
    Total Current Liabilities48,632,000USD47,028,000USD39,277,000USD26,112,000USD28,832,000USD26,976,000USD34,065,000USD34,481,000USD
    Other Current Liabilities1,423,000USD1,408,000USD1,362,000USD8,990,000USD6,866,000USD———
    Other Non Current Liabilities2,087,000USD1,859,000USD1,713,000USD3,995,000USD3,316,000USD———
    Total Stockholder Equity217,652,000USD205,804,000USD154,657,000USD133,165,000USD117,230,000USD41,023,000USD39,666,000USD69,770,000USD
    Total Equity Including Noncontrolling Interest217,652,000USD205,804,000USD154,657,000USD133,165,000USD117,230,000USD———
    Long Term Debt0USD0USD61,928,000USD61,310,000USD60,692,000USD60,090,000USD59,504,000USD58,904,000USD
    Net Receivables22,489,000USD22,098,000USD23,258,000USD16,841,000USD18,266,000USD12,617,000USD10,509,000USD7,790,000USD
    Inventory2,449,000USD2,310,000USD1,740,000USD1,367,000USD1,108,000USD2,559,000USD1,970,000USD8,756,000USD
    Property Plant Equipment Net2,308,000USD1,517,000USD1,701,000USD1,825,000USD2,095,000USD2,058,000USD1,013,000USD1,427,000USD
    Goodwill4,701,000USD4,701,000USD4,701,000USD4,701,000USD4,701,000USD———
    Intangible Assets5,789,000USD6,105,000USD6,421,000USD6,737,000USD7,053,000USD67,377,000USD68,993,000USD70,608,000USD
    Accounts Payable13,962,000USD11,688,000USD2,478,000USD11,072,000USD15,842,000USD17,819,000USD13,075,000USD24,464,000USD
    Short Term Debt626,000USD406,000USD419,000USD441,000USD525,000USD589,000USD420,000USD540,000USD
    Retained Earnings-375,418,000USD-384,170,000USD-422,060,000USD-434,225,000USD-433,681,000USD-508,388,000USD-505,289,000USD-469,550,000USD
    Accumulated Other Comprehensive Income-2,217,000USD-1,797,000USD-764,000USD-2,416,000USD-2,428,000USD-82,000USD631,000USD-115,000USD
    Total Liab—————131,685,000USD138,461,000USD121,781,000USD
    Other Current Liab—————26,387,000USD20,570,000USD33,941,000USD
    Common Stock—————5,000USD5,000USD5,000USD
    Capital Stock—————5,000USD5,000USD5,000USD
    Good Will—————4,701,000USD4,701,000USD4,701,000USD
    Cash—————37,340,000USD33,785,000USD54,039,000USD
    Cash And Short Term Investments—————62,631,000USD69,496,000USD89,376,000USD
    Net Debt—————24,497,000USD26,511,000USD5,888,000USD
    Short Long Term Debt Total—————61,837,000USD60,296,000USD59,927,000USD
    Long Term Investments—————6,091,000USD6,010,000USD6,105,000USD
    Short Term Investments—————25,291,000USD35,711,000USD35,337,000USD
    Property Plant Equipment Gross—————2,058,000USD2,739,000USD1,427,000USD
    Common Stock Shares Outstanding—————54,095,543shares53,670,709shares47,808,817shares
    Non Current Assets Total—————91,135,000USD92,100,000USD92,109,000USD
    Non Current Liabilities Total—————104,709,000USD104,396,000USD87,300,000USD
    Non Current Liabilities Other—————14,265,000USD12,285,000USD14,011,000USD
    Non Currrent Assets Other—————10,908,000USD11,383,000USD9,268,000USD
    Net Working Capital—————54,597,000USD51,962,000USD64,961,000USD
    Unclassified Current Liabilities—————-17,819,000USD—-24,464,000USD
    Unclassified Non Current Liabilities—————30,354,000USD32,607,000USD14,385,000USD
    Unclassified Equity—————549,483,000USD544,314,000USD539,425,000USD
    Unclassified Current Assets———————-8,756,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets284,731,000USD178,127,000USD172,327,000USD115,340,000USD132,941,000USD11,209,000USD10,507,000USD26,746,000USD
    Cash And Equivalents62,406,000USD———————
    Total Current Assets223,007,000USD86,027,000USD86,938,000USD92,834,000USD115,056,000USD8,382,000USD6,972,000USD23,721,000USD
    Other Current Assets6,998,000USD4,052,000USD-22,258,000USD1,688,000USD1,182,000USD1,590,000USD1,890,000USD1,912,000USD
    Other Non Current Assets143,000USD———————
    Total Liabilities130,074,000USD———————
    Total Current Liabilities39,277,000USD34,065,000USD73,720,000USD12,023,000USD4,230,000USD7,536,000USD5,431,000USD12,004,000USD
    Other Current Liabilities1,362,000USD———————
    Other Non Current Liabilities1,713,000USD———————
    Total Stockholder Equity154,657,000USD39,666,000USD61,864,000USD75,120,000USD127,118,000USD-66,412,000USD-74,456,000USD-66,566,000USD
    Total Equity Including Noncontrolling Interest154,657,000USD———————
    Long Term Debt61,928,000USD59,504,000USD5,066,000USD12,800,000USD—68,049,000USD77,343,000USD—
    Net Receivables23,258,000USD10,509,000USD17,377,000USD8,299,000USD1,528,000USD2,579,000USD1,865,000USD140,000USD
    Inventory1,740,000USD1,970,000USD24,082,000USD—1USD109,000USD—224,000USD
    Property Plant Equipment Net1,701,000USD1,013,000USD1,526,000USD1,782,000USD2,025,000USD2,389,000USD3,008,000USD1,753,000USD
    Goodwill4,701,000USD———————
    Intangible Assets6,421,000USD68,993,000USD69,227,000USD—————
    Accounts Payable2,478,000USD13,075,000USD13,987,000USD3,611,000USD516,000USD1,174,000USD1,140,000USD3,715,000USD
    Short Term Debt419,000USD420,000USD38,243,000USD5,135,000USD371,000USD889,000USD284,000USD3,547,000USD
    Retained Earnings-422,060,000USD-505,289,000USD-399,778,000USD-353,729,000USD-267,029,000USD-258,474,000USD-245,714,000USD-221,192,000USD
    Accumulated Other Comprehensive Income-764,000USD631,000USD-43,000USD113,000USD0USD0USD——
    Total Liab—138,461,000USD110,463,000USD40,220,000USD5,823,000USD77,621,000USD84,963,000USD93,312,000USD
    Other Current Liab—6,139,000USD21,490,000USD3,277,000USD3,343,000USD5,473,000USD4,007,000USD115,000USD
    Common Stock—5,000USD4,000USD3,000USD4,000USD—4,000USD3,000USD
    Capital Stock—5,000USD4,000USD3,000USD4,000USD0USD4,000USD—
    Good Will—4,701,000USD4,701,000USD0USD————
    Cash—33,785,000USD43,049,000USD65,466,000USD112,346,000USD4,213,000USD3,217,000USD18,409,000USD
    Cash And Short Term Investments—69,496,000USD67,737,000USD82,847,000USD112,346,000USD4,213,000USD3,217,000USD21,669,000USD
    Net Debt—26,511,000USD716,000USD-46,688,000USD-110,737,000USD66,334,000USD76,311,000USD63,639,000USD
    Short Long Term Debt Total—60,296,000USD43,765,000USD18,778,000USD1,609,000USD70,547,000USD79,528,000USD82,048,000USD
    Long Term Investments—6,010,000USD0USD20,000,000USD15,422,000USD0USD——
    Short Term Investments—35,711,000USD24,688,000USD17,381,000USD0USD—0USD3,260,000USD
    Property Plant Equipment Gross—2,739,000USD3,160,000USD1,782,000USD2,025,000USD2,389,000USD3,008,000USD—
    Common Stock Shares Outstanding—46,251,239shares35,452,460shares34,488,800shares29,766,347shares3,980,975shares1,853,435shares1,120,626shares
    Non Current Assets Total—92,100,000USD85,389,000USD22,506,000USD17,885,000USD2,827,000USD3,535,000USD3,025,000USD
    Non Current Liabilities Total—104,396,000USD36,743,000USD28,197,000USD1,593,000USD70,085,000USD79,532,000USD81,308,000USD
    Non Current Liabilities Other—12,285,000USD15,121,000USD4,352,000USD31,000USD145,000USD168,000USD—
    Non Currrent Assets Other—11,383,000USD9,935,000USD724,000USD438,000USD438,000USD527,000USD1,272,000USD
    Net Working Capital—51,962,000USD13,218,000USD81,297,000USD110,826,000USD846,000USD1,203,000USD—
    Unclassified Current Liabilities—14,431,000USD-45,995,000USD-9,310,000USD-2,522,000USD-5,863,000USD-3,771,000USD—
    Unclassified Non Current Liabilities—32,607,000USD16,556,000USD6,692,000USD1,207,000USD1,464,000USD1,901,000USD81,308,000USD
    Unclassified Equity—544,314,000USD461,677,000USD428,730,000USD394,139,000USD192,062,000USD171,250,000USD154,623,000USD
    Current Deferred Revenue——8,295,000USD4,655,000USD2,522,000USD5,473,000USD3,771,000USD4,627,000USD
    Short Long Term Debt——37,700,000USD4,655,000USD—390,000USD——
    Unclassified Current Assets——-22,258,000USD—————
    Other Liab———4,353,000USD355,000USD427,000USD120,000USD—
    Other Assets———724,000USD438,000USD438,000USD527,000USD—
    Net Tangible Assets———85,807,000USD127,118,000USD-66,412,000USD-74,456,000USD—
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Depreciation368,000USD362,000USD392,000USD1,651,000USD1,649,000USD1,648,000USD1,617,000USD1,562,000USD
    Stock Based Compensation3,105,000USD4,284,000USD2,771,000USD2,464,000USD3,115,000USD4,018,000USD6,137,000USD2,632,000USD
    Other Non Cash Items-2,756,000USD-1,745,000USD4,851,000USD-77,333,000USD-4,225,000USD11,996,000USD7,569,000USD-1,938,000USD
    Change To Inventory-185,000USD-525,000USD-194,000USD-381,000USD-205,000USD502,000USD-583,000USD-991,000USD
    Change To Liabilities-113,000USD———————
    Change In Working Capital1,252,000USD-10,051,000USD-2,328,000USD-7,289,000USD-6,844,000USD1,827,000USD-239,000USD-1,440,000USD
    Operating Cash Flow6,142,000USD———————
    Capital Expenditures-35,000USD-31,000USD-554,000USD-213,000USD-99,000USD0USD0USD0USD
    Net Investments35,676,000USD———————
    Unclassified Investing Cash Flow43,977,000USD—149,965,000USD-149,787,000USD—-8,922,000USD——
    Investing Cash Flow79,618,000USD———————
    Net Debt Issuance-60,092,000USD———————
    Common Stock Issuance752,000USD———————
    Net Common Stock Issuance-2,635,000USD———————
    Unclassified Financing Cash Flow9,171,000USD-8,639,000USD—1,381,000USD—-82,109,000USD64,673,000USD16,219,000USD
    Financing Cash Flow-52,804,000USD———————
    Effect Of Forex Changes On Cash233,000USD———————
    Change In Cash33,189,000USD7,967,000USD6,727,000USD10,372,000USD3,555,000USD-20,254,000USD14,779,000USD-3,589,000USD
    End Cash Flow95,595,000USD———————
    Net Income—12,165,000USD-544,000USD74,707,000USD-3,099,000USD-35,739,000USD-33,225,000USD-19,925,000USD
    Change To Account Receivables—-6,367,000USD1,359,000USD-4,861,000USD-2,108,000USD-3,361,000USD1,157,000USD-642,000USD
    Total Cash From Operating Activities—5,516,000USD4,709,000USD-3,601,000USD-8,222,000USD-16,250,000USD-18,141,000USD-19,109,000USD
    Free Cash Flow—5,547,000USD4,155,000USD-3,814,000USD-8,321,000USD-16,250,000USD-18,141,000USD-19,109,000USD
    Investments—337,000USD-4,576,000USD11,934,000USD10,542,000USD-5,471,000USD-31,354,000USD-129,000USD
    Total Cashflows From Investing Activities—227,000USD-4,576,000USD11,934,000USD10,542,000USD-5,471,000USD-31,354,000USD-129,000USD
    Net Borrowings—0USD0USD0USD0USD0USD0USD—
    Total Cash From Financing Activities—2,546,000USD6,530,000USD1,381,000USD1,607,000USD796,000USD64,765,000USD15,330,000USD
    Issuance Of Capital Stock—8,639,000USD——0USD-1,303,000USD64,673,000USD-71,000USD
    Begin Period Cash Flow—54,439,000USD47,712,000USD37,340,000USD33,785,000USD54,039,000USD39,260,000USD42,849,000USD
    End Period Cash Flow—62,406,000USD54,439,000USD47,712,000USD37,340,000USD33,785,000USD54,039,000USD39,260,000USD
    Other Cashflows From Investing Activities—-141,000USD-149,411,000USD150,000,000USD—8,922,000USD—-129,000USD
    Other Cashflows From Financing Activities—2,546,000USD6,530,000USD—1,607,000USD82,905,000USD92,000USD-889,000USD
    Unclassified Operating Cash Flow———2,199,000USD1,182,000USD———
    Sale Purchase Of Stock—————0USD0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Depreciation4,054,000USD6,389,000USD1,006,000USD944,000USD257,000USD273,000USD304,000USD324,000USD
    Stock Based Compensation12,634,000USD14,906,000USD5,954,000USD4,294,000USD2,436,000USD2,491,000USD4,410,000USD6,495,000USD
    Deferred Income Tax-9,846,000USD———————
    Change To Inventory-1,305,000USD-8,874,000USD206,000USD147,000USD147,000USD-217,000USD5,514,000USD—
    Change To Liabilities-16,746,000USD——3,131,000USD-1,113,000USD931,000USD-3,789,000USD—
    Change In Working Capital-19,384,000USD-6,640,000USD5,883,000USD-406,000USD-357,000USD374,000USD-5,120,000USD-2,285,000USD
    Operating Cash Flow-1,598,000USD———————
    Capital Expenditures-835,000USD0USD-296,000USD-93,000USD-102,000USD-33,000USD-26,000USD-21,000USD
    Net Investments-131,486,000USD———————
    Unclassified Investing Cash Flow150,448,000USD6,000,000USD10,944,000USD36,719,000USD15,524,000USD—-3,234,000USD—
    Investing Cash Flow18,127,000USD———————
    Net Debt Issuance0USD———————
    Unclassified Financing Cash Flow12,064,000USD64,516,000USD——86,036,000USD2,219,000USD1,609,000USD28,135,000USD
    Financing Cash Flow12,064,000USD———————
    Effect Of Forex Changes On Cash28,000USD———————
    Change In Cash28,621,000USD-9,264,000USD-22,417,000USD-46,880,000USD108,024,000USD767,000USD-15,564,000USD7,148,000USD
    End Cash Flow62,406,000USD———————
    Net Income—-105,511,000USD-46,049,000USD-41,543,000USD-8,555,000USD-12,760,000USD-24,522,000USD-56,466,000USD
    Other Non Cash Items—5,817,000USD-329,000USD17,994,000USD460,000USD7,248,000USD3,189,000USD3,707,000USD
    Change To Account Receivables—6,868,000USD-9,078,000USD-6,772,000USD1,051,000USD-714,000USD-1,725,000USD—
    Total Cash From Operating Activities—-69,665,000USD-33,535,000USD-18,717,000USD10,439,000USD-1,939,000USD-23,737,000USD-54,203,000USD
    Free Cash Flow—-69,665,000USD-33,831,000USD-18,810,000USD10,337,000USD-1,972,000USD-23,763,000USD-54,224,000USD
    Investments—-22,161,000USD-28,038,000USD-36,719,000USD-15,524,000USD-33,000USD3,234,000USD—
    Total Cashflows From Investing Activities—-22,161,000USD-17,390,000USD-36,719,000USD-15,524,000USD-33,000USD3,234,000USD33,332,000USD
    Net Borrowings—16,290,000USD24,895,000USD12,751,000USD-38,097,000USD554,000USD-207,000USD—
    Total Cash From Financing Activities—82,108,000USD28,464,000USD8,352,000USD113,109,000USD2,739,000USD4,939,000USD28,019,000USD
    Sale Purchase Of Stock—0USD-3,447,000USD-4,723,000USD-2,814,000USD0USD——
    Issuance Of Capital Stock—64,516,000USD6,106,000USD36,751,000USD86,036,000USD2,303,000USD3,837,000USD—
    Begin Period Cash Flow—43,049,000USD65,466,000USD112,346,000USD4,322,000USD3,555,000USD19,119,000USD11,971,000USD
    End Period Cash Flow—33,785,000USD43,049,000USD65,466,000USD112,346,000USD4,322,000USD3,555,000USD19,119,000USD
    Other Cashflows From Investing Activities—-6,000,000USD—-36,626,000USD-15,422,000USD—3,260,000USD33,353,000USD
    Other Cashflows From Financing Activities—1,302,000USD6,324,000USD291,000USD98,803,000USD-34,000USD-300,000USD-116,000USD
    Unclassified Operating Cash Flow—15,374,000USD——16,198,000USD—-1,998,000USD-5,978,000USD
    Dividends Paid———-324,000USD-30,819,000USD———
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ3 20252025-09-30 · USDQ2 20252025-06-30 · USD
    Depreciation3,692,000USD3,300,000USD
    Stock Based Compensation8,350,000USD5,579,000USD
    Change To Inventory-780,000USD-586,000USD
    Change To Liabilities-11,176,000USD-9,278,000USD
    Change In Working Capital-20,121,000USD-12,151,000USD
    Operating Cash Flow-7,114,000USD-11,823,000USD
    Capital Expenditures-866,000USD-312,000USD
    Net Investments-131,823,000USD-127,212,000USD
    Unclassified Investing Cash Flow150,589,000USD150,000,000USD
    Investing Cash Flow17,900,000USD22,476,000USD
    Net Debt Issuance0USD0USD
    Common Stock Issuance3,520,000USD—
    Unclassified Financing Cash Flow5,998,000USD2,988,000USD
    Financing Cash Flow9,518,000USD2,988,000USD
    Effect Of Forex Changes On Cash350,000USD286,000USD
    Change In Cash20,654,000USD13,927,000USD
    End Cash Flow54,439,000USD47,712,000USD
    SourceDisclosureDeterministicFinalDisclosureDeterministicFinal

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30ProductMIPLYFFA30,200,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOLPRUVA200,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30ProductOther9,263,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductMIPLYFFA87,400,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductOlpruva800,000USDDisclosure
    FY 2025Yearly · 2025-12-31ProductOther18,270,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductMIPLYFFA22,400,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductOLPRUVA100,000USDDisclosure
    Q3 2025Quarterly · 2025-09-30ProductOther3,563,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductLicense0USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductMIPLYFFA21,500,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductOLPRUVA300,000USDDisclosure
    Q2 2025Quarterly · 2025-06-30ProductOther4,081,000USDDisclosure
    Q1 2022Quarterly · 2022-03-31ProductConsulting Services3,500,000USD0001437749-23-014683
    Q1 2022Quarterly · 2022-03-31ProductLicense100,000USD0001437749-23-014683
    Q1 2022Quarterly · 2022-03-31ProductOther365,000USD0001437749-23-014683
    Q2 2021Quarterly · 2021-06-30ProductConsulting Services300,000USD0001437749-22-020394
    Q2 2021Quarterly · 2021-06-30ProductLicense10,000,000USD0001437749-22-020394
    Q2 2021Quarterly · 2021-06-30ProductOther1,686,000USD0001437749-22-020394
    Q1 2021Quarterly · 2021-03-31ProductConsulting Services500,000USD0001437749-22-012182
    Q1 2021Quarterly · 2021-03-31ProductLicense10,000,000USD0001437749-22-012182
    Q1 2021Quarterly · 2021-03-31ProductOther1,617,000USD0001437749-22-012182
    FY 2020Yearly · 2020-12-31ProductConsulting Services3,900,000USD0001437749-21-005785
    FY 2020Yearly · 2020-12-31ProductLicense7,300,000USD0001437749-21-005785
    FY 2020Yearly · 2020-12-31ProductOther2,088,000USD0001437749-21-005785
    Q2 2020Quarterly · 2020-06-30ProductConsulting Services1,300,000USD0001437749-21-019912
    Q2 2020Quarterly · 2020-06-30ProductLicense5,600,000USD0001437749-21-019912
    Q2 2020Quarterly · 2020-06-30ProductOther8,000USD0001437749-21-019912
    Q1 2020Quarterly · 2020-03-31ProductConsulting Services0USD0001437749-21-012167
    Q1 2020Quarterly · 2020-03-31ProductLicense2,100,000USD0001437749-21-012167
    FY 2019Yearly · 2019-12-31ProductConsulting Services1,700,000USD0001437749-20-003965
    FY 2019Yearly · 2019-12-31ProductLicense10,000,000USD0001437749-20-003965
    FY 2019Yearly · 2019-12-31ProductOther39,000USD0001437749-20-003965
    FY 2019Yearly · 2019-12-31ProductReimbursement Of Out Of Pocket Third Party Research And Development Costs1,100,000USD0001437749-20-003965

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.